“Magic mushrooms” might serve a purpose other than turning trees into rainbows, after all. Recent tests at UCLA show that the drug reduces anxiety among terminal cancer patients. The LA Times reports on the study:
The patients were given a relatively low dose of psilocybin, 0.2 milligram per kilogram of body weight. Nonetheless, the team reported in the Archives of General Psychiatry, all patients reported a significant improvement in mood for at least two weeks after the psilocybin treatment and up to a six-month improvement on a scale that measures depression and anxiety. Most also reported a decreased need for narcotic pain relievers. No adverse reactions were observed.